Elsa Bey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elsa Bey has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
C. Lanchon
Service d'urologie, CHU de Grenoble, 38043 Grenoble, France; UJF-Grenoble 1, CNRS, Inserm, TIMC-IMAG UMR 5525, 38041 Grenoble, France
5 shared publicationsD. Carnicelli
Service d'urologie, CHU de Grenoble, 38043 Grenoble, France
5 shared publicationsD. Poncet
Service d'urologie, CHU de Grenoble, 38043 Grenoble, France
5 shared publicationsG. Fiard
Service d'urologie, CHU de Grenoble, 38043 Grenoble, France; UJF-Grenoble 1, CNRS, Inserm, TIMC-IMAG UMR 5525, 38041 Grenoble, France
5 shared publicationsN. Peilleron
Service d'urologie, CHU de Grenoble, 38043 Grenoble, France
5 shared publicationsQ. Franquet
Service d'urologie, CHU de Grenoble, 38043 Grenoble, France
5 shared publications
Latest Publications
- 31 May 2022
- Published by Elsevier in Progrès en Urologie
- Vol. 32 (10) , 635-655
Priorisation des situations à risque en neuro-urologie : recommandations par méthode Delphi de l’Association française d’urologie (AFU), l’Association francophone internationale des groupes d’animation de la paraplégie (AFIGAP), le Groupe de neuro-urologie de langue française (GENULF), la Société française de médecine physique et de réadaptation (SOFMER) et la Société interdisciplinaire francophone d’urodynamique et de pelvi-périnéologie (SIFUD-PP)
- 31 May 2022
- Published by Elsevier in Progrès en Urologie
- Vol. 32 (10) , 635-655
Priorisation des situations à risque en neuro-urologie : recommandations par méthode Delphi de l’Association française d’urologie (AFU), l’Association francophone internationale des groupes d’animation de la paraplégie (AFIGAP), le Groupe de neuro-urologie de langue française (GENULF), la Société française de médecine physique et de réadaptation (SOFMER) et la Société interdisciplinaire francophone d’urodynamique et de pelvi-périnéologie (SIFUD-PP)
- 1 November 2021
- Published by Elsevier in Progrès en Urologie
- Vol. 31 (14) , 917-923
Les sondes en urologie : indications et prise en charge infirmière
- 1 November 2021
- Published by Elsevier in Progrès en Urologie
- Vol. 31 (14) , 917-923
Les sondes en urologie : indications et prise en charge infirmière
- 17 August 2021
- Published by Springer Nature in World Journal of Urology
- Vol. 40 (1) , 133-139
Prioritization of risk situations in neuro-urology: guidelines from Association Française d’Urologie (AFU), Association Francophone Internationale des Groupes d’Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)
Purpose The current health crisis has drastically impacted patient management in many fields, including neuro-urology, leading to a mandatory reorganization. The aim of this work was to establish guidelines regarding the prioritization and optimal timing of each step of neurogenic lower urinary tract dysfunction management. Methods A steering committee included urologists and physical medicine and rehabilitation practitioners. Based on a literature review and their own expertise, they established a comprehensive risk-situation list and built a risk scale, allowing multiple other experts to score each clinical situation. New recommendations were generated using a Delphi process approach. Results Forty-nine experts participated in the rating group. Among the 206 initial items, 163 were selected and divided into four domains, diagnosis and assessment, treatment, follow-up, and complications, and two sub-domains, general (applicable for all neurological conditions) and condition-specific [varying according to the neurological condition (spinal cord injury, multiple sclerosis, brain injury, Parkinsonism, dysraphism, lower motor neuron lesions)]. The resulted guidelines are expert opinions established by a panel of French-speaking specialists, which could limit the scalability of this work. Conclusions The present multidisciplinary collaborative work generates recommendations which complement existing guidelines and help clinicians to reorganize their patients’ list in the long term with a personalized medicine approach, in the context of health crisis or not.
- 17 August 2021
- Published by Springer Nature in World Journal of Urology
- Vol. 40 (1) , 133-139
Prioritization of risk situations in neuro-urology: guidelines from Association Française d’Urologie (AFU), Association Francophone Internationale des Groupes d’Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)
Purpose The current health crisis has drastically impacted patient management in many fields, including neuro-urology, leading to a mandatory reorganization. The aim of this work was to establish guidelines regarding the prioritization and optimal timing of each step of neurogenic lower urinary tract dysfunction management. Methods A steering committee included urologists and physical medicine and rehabilitation practitioners. Based on a literature review and their own expertise, they established a comprehensive risk-situation list and built a risk scale, allowing multiple other experts to score each clinical situation. New recommendations were generated using a Delphi process approach. Results Forty-nine experts participated in the rating group. Among the 206 initial items, 163 were selected and divided into four domains, diagnosis and assessment, treatment, follow-up, and complications, and two sub-domains, general (applicable for all neurological conditions) and condition-specific [varying according to the neurological condition (spinal cord injury, multiple sclerosis, brain injury, Parkinsonism, dysraphism, lower motor neuron lesions)]. The resulted guidelines are expert opinions established by a panel of French-speaking specialists, which could limit the scalability of this work. Conclusions The present multidisciplinary collaborative work generates recommendations which complement existing guidelines and help clinicians to reorganize their patients’ list in the long term with a personalized medicine approach, in the context of health crisis or not.
- 14 June 2021
- Published by Springer Nature in International Urogynecology Journal
- Vol. 32 (7) , 1707-1717
Outcomes of pregnancy and delivery in women with continent lower urinary tract reconstruction: systematic review of the literature
Introduction and hypothesis The aim of this systematic review of the literature was to pool all the existing data regarding pregnancy and delivery in women with neurogenic bladder or bladder exstrophy who had undergone previous lower urinary tract reconstruction (LUTR). Methods We conducted a systematic review of the literature from PubMed/MedLine, ClinicalTrials.gov and the Google Scholar database, from 1972 to July 2020. Fifty articles were included, of which 25 contained data that could be pooled (229 women representing 292 pregnancies). Results Ninety-eight women had bladder exstrophy (43%), 58 had spinal dysraphism (25%), 14 had spinal cord injury (6%), and 59 presented other pathological conditions. Of these, 138 have had an augmentation cystoplasty (61%), 42 (18%) had a continent cutaneous urinary diversion, and 31 had an artificial urinary sphincter (14%). During their pregnancy, 97 women (33%) experienced at least one febrile urinary tract infection. Thirty-one women (11%) required ureteral stenting or nephrostomy placement for upper urinary tract dilatation. Forty-six pregnancies ended with premature delivery (16%). Delivery mode was by C-section for 108 patients (62%) and vaginal delivery for 104 (36%). Twenty complications were reported during delivery (mainly urological), of which 19 occurred during C-section. Nine women experienced postpartum urinary incontinence (4%); in 5 of then this was due to urinary fistulae secondary to complicated C-section. Conclusions Pregnancy and vaginal delivery are possible for women with LUTR who have no obstetric or medical contraindications, except for some particular cases of bladder exstrophy. However, these high-risk pregnancies and deliveries should be managed by a specialist multidisciplinary team.
- 14 June 2021
- Published by Springer Nature in International Urogynecology Journal
- Vol. 32 (7) , 1707-1717
Outcomes of pregnancy and delivery in women with continent lower urinary tract reconstruction: systematic review of the literature
Introduction and hypothesis The aim of this systematic review of the literature was to pool all the existing data regarding pregnancy and delivery in women with neurogenic bladder or bladder exstrophy who had undergone previous lower urinary tract reconstruction (LUTR). Methods We conducted a systematic review of the literature from PubMed/MedLine, ClinicalTrials.gov and the Google Scholar database, from 1972 to July 2020. Fifty articles were included, of which 25 contained data that could be pooled (229 women representing 292 pregnancies). Results Ninety-eight women had bladder exstrophy (43%), 58 had spinal dysraphism (25%), 14 had spinal cord injury (6%), and 59 presented other pathological conditions. Of these, 138 have had an augmentation cystoplasty (61%), 42 (18%) had a continent cutaneous urinary diversion, and 31 had an artificial urinary sphincter (14%). During their pregnancy, 97 women (33%) experienced at least one febrile urinary tract infection. Thirty-one women (11%) required ureteral stenting or nephrostomy placement for upper urinary tract dilatation. Forty-six pregnancies ended with premature delivery (16%). Delivery mode was by C-section for 108 patients (62%) and vaginal delivery for 104 (36%). Twenty complications were reported during delivery (mainly urological), of which 19 occurred during C-section. Nine women experienced postpartum urinary incontinence (4%); in 5 of then this was due to urinary fistulae secondary to complicated C-section. Conclusions Pregnancy and vaginal delivery are possible for women with LUTR who have no obstetric or medical contraindications, except for some particular cases of bladder exstrophy. However, these high-risk pregnancies and deliveries should be managed by a specialist multidisciplinary team.
- 1 April 2021
- Published by Elsevier in Progrès en Urologie
- Vol. 31 (5) , 245-248
Recommandations courtes du CIAFU : intérêt de l’ECBU avant biopsie de la prostate réalisée par voie endo-rectale
- 1 April 2021
- Published by Elsevier in Progrès en Urologie
- Vol. 31 (5) , 245-248
Recommandations courtes du CIAFU : intérêt de l’ECBU avant biopsie de la prostate réalisée par voie endo-rectale
- 1 February 2021
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 66 (1) , 10-18
Place actuelle des cultures d’épidermes autologues dans la prise en charge des brûlures étendues et perspective d’avenir : revue de littérature
- 1 February 2021
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 66 (1) , 10-18
Place actuelle des cultures d’épidermes autologues dans la prise en charge des brûlures étendues et perspective d’avenir : revue de littérature
- 16 November 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (1) , 412-420
Long‐term outcomes of artificial urinary sphincter in female patients with spina bifida
Aims: To report the long‐term functional outcomes of artificial urinary sphincter (AUS) implantation in female patients with spinal dysraphism and stress urinary incontinence (SUI) related to intrinsic sphincter deficiency (ISD).Methods: The charts of all spina bifida female patients with SUI due to ISD who underwent AUS (AMS 800) implantation between 2005 and 2019 at three academic departments of urology were retrospectively reviewed. Reoperation was defined as either revision or explantation of the AUS device. Reoperation‐free survival of the AUS device was estimated using the Kaplan–Meier method. Continence status as per patients' subjective assessment was categorized as follows: complete continence (no pads), improved continence, unchanged SUI or worsened SUI.Results: Twenty‐three patients were included, 69.6% were self‐catheterizing. The median follow‐up was 14 years. Median time to first reoperation was 10 years. Survival rates without reoperation were 85.9%, 41.8%, 34.6%, and 20.9% at 5, 10, 15, 20 years, respectively. Survival rates without AUS explantation were 90.7%, 66.3%, 55.2%, and 41.4% at 5, 10, 15, 20 years, respectively. None of the patients who underwent device explantation had a new AUS implanted. The only predictive factor of reoperation‐free survival was the type of spinal dysraphism (hazards ratio = 3.60 for closed vs. open dysraphism; p = .04). At last follow‐up, 17 of the 23 patients were fully continent (73.9%).Conclusion: AUS in female patients with spina bifida may be associated with satisfactory long‐term functional outcomes and a high reoperation rate. The median time to first reoperation was similar to what is reported in the male AUS literature (10 years).
- 16 November 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (1) , 412-420
Long‐term outcomes of artificial urinary sphincter in female patients with spina bifida
Aims: To report the long‐term functional outcomes of artificial urinary sphincter (AUS) implantation in female patients with spinal dysraphism and stress urinary incontinence (SUI) related to intrinsic sphincter deficiency (ISD).Methods: The charts of all spina bifida female patients with SUI due to ISD who underwent AUS (AMS 800) implantation between 2005 and 2019 at three academic departments of urology were retrospectively reviewed. Reoperation was defined as either revision or explantation of the AUS device. Reoperation‐free survival of the AUS device was estimated using the Kaplan–Meier method. Continence status as per patients' subjective assessment was categorized as follows: complete continence (no pads), improved continence, unchanged SUI or worsened SUI.Results: Twenty‐three patients were included, 69.6% were self‐catheterizing. The median follow‐up was 14 years. Median time to first reoperation was 10 years. Survival rates without reoperation were 85.9%, 41.8%, 34.6%, and 20.9% at 5, 10, 15, 20 years, respectively. Survival rates without AUS explantation were 90.7%, 66.3%, 55.2%, and 41.4% at 5, 10, 15, 20 years, respectively. None of the patients who underwent device explantation had a new AUS implanted. The only predictive factor of reoperation‐free survival was the type of spinal dysraphism (hazards ratio = 3.60 for closed vs. open dysraphism; p = .04). At last follow‐up, 17 of the 23 patients were fully continent (73.9%).Conclusion: AUS in female patients with spina bifida may be associated with satisfactory long‐term functional outcomes and a high reoperation rate. The median time to first reoperation was similar to what is reported in the male AUS literature (10 years).
- 24 August 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (8) , 2230-2237
Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial
Aim: To compare treatment success rate in terms of improvement of bladder overactivity between unilateral and bilateral sacral neuromodulation testing.Methods: A multicentric, parallel, randomized, open pilot trial (October 2012‐September 2017) was conducted. Participants presented primary overactive bladder resistant to first‐line treatments. Patients were excluded in case of secondary bladder, pelvic, or neurological condition. Patients were randomized between bilateral testing (n = 28) or unilateral testing (n = 27), to determine the best functional response before final implantation. The primary outcome was the rate of patients presenting at least 50% of clinical improvement at 1 month on urinary frequency, number of urge incontinence episodes or number of urinary urgency episodes. Symptom severity, implantation success rate, uroflowmetry, device tolerance, complications, and quality of life were also assessed.Results: Fifty‐five patients have been included. The rate of patients presenting at least one significant clinical improvement at month 1 was 62% in the bilateral group versus 84% in the unilateral group (P = .0891), RR = 0.74 (0.51; 1.07). There was no significant difference between bilateral and unilateral groups in terms of improvement of urinary frequency (0% and 17%; P = .1115), number of urge incontinence episodes (52% and 63%; P = .4929) or number of urinary urgency episodes (57% and 74%; P = .2411). More complications were reported in the bilateral group than in the unilateral group (9 [47%] vs 4 [16%], respectively; P = .0239).Conclusion: Systematic bilateral sacral neuromodulation testing before final implantation did not appear to increase success rate compared with unilateral stimulation in the treatment of overactive bladder.
- 24 August 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (8) , 2230-2237
Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial
Aim: To compare treatment success rate in terms of improvement of bladder overactivity between unilateral and bilateral sacral neuromodulation testing.Methods: A multicentric, parallel, randomized, open pilot trial (October 2012‐September 2017) was conducted. Participants presented primary overactive bladder resistant to first‐line treatments. Patients were excluded in case of secondary bladder, pelvic, or neurological condition. Patients were randomized between bilateral testing (n = 28) or unilateral testing (n = 27), to determine the best functional response before final implantation. The primary outcome was the rate of patients presenting at least 50% of clinical improvement at 1 month on urinary frequency, number of urge incontinence episodes or number of urinary urgency episodes. Symptom severity, implantation success rate, uroflowmetry, device tolerance, complications, and quality of life were also assessed.Results: Fifty‐five patients have been included. The rate of patients presenting at least one significant clinical improvement at month 1 was 62% in the bilateral group versus 84% in the unilateral group (P = .0891), RR = 0.74 (0.51; 1.07). There was no significant difference between bilateral and unilateral groups in terms of improvement of urinary frequency (0% and 17%; P = .1115), number of urge incontinence episodes (52% and 63%; P = .4929) or number of urinary urgency episodes (57% and 74%; P = .2411). More complications were reported in the bilateral group than in the unilateral group (9 [47%] vs 4 [16%], respectively; P = .0239).Conclusion: Systematic bilateral sacral neuromodulation testing before final implantation did not appear to increase success rate compared with unilateral stimulation in the treatment of overactive bladder.
- 1 April 2020
- Published by Elsevier in Progrès en Urologie
- Vol. 30 (5) , 261-266
Évaluation des pratiques professionnelles françaises par questionnaire en 2019 concernant la prévention et le traitement des infections urinaires sur matériel endo-urétéral
- 1 April 2020
- Published by Elsevier in Progrès en Urologie
- Vol. 30 (5) , 261-266
Évaluation des pratiques professionnelles françaises par questionnaire en 2019 concernant la prévention et le traitement des infections urinaires sur matériel endo-urétéral
- 1 December 2018
- Published by Elsevier in Progrès en Urologie - FMC
- Vol. 28 (4) , F103-F106
Résistances bactériennes : que doit savoir l’urologue ?
- 1 December 2018
- Published by Elsevier in Progrès en Urologie - FMC
- Vol. 28 (4) , F103-F106
Résistances bactériennes : que doit savoir l’urologue ?